Go to Top
(312) 587-0087gjohnson@tracttherapeutics.com
    TRACT Therapeutics, Inc.
    • Home
    • About
      • Management & Advisors
    • Technology Overview
      • Organ Transplantation
    • Clinical Pipeline
    • Patients
      • TRACT CryoBanking Program
    • Investors
    • News
    • Contact
    • Home
    • About
    • Management & Advisors
    • Technology Overview
    • Organ Transplantation
    • Clinical Pipeline
    • Patients
    • Investors
    • News & Events
    • Contact

    Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in De Novo Living Donor Kidney Transplant Recipients

    • TRACT Therapeutics, Inc./
    • Blog/
    • Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in De Novo Living Donor Kidney Transplant Recipients
    • TRACT Therapeutics, Inc. Launches the TRACT CryoBanking Program™ to Collect and Bank a Patient’s Immune Cells for Future Treatment
    Jun 25 2016

    Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in De Novo Living Donor Kidney Transplant Recipients

    Download Full Presentation

    Posted in: Uncategorized
      © TRACT Therapeutics, Inc. 2015